Glaukos (GKOS) X Mentions Statistics 2025

5 66.7%

Est. daily mentions of Cashtag on X.

Similar companies

Company		X Mentions
	Boston Scientific BSX	19 26.9%
	Edwards Lifesciences EW	10 44.4%
	Intuitive Surgical ISRG	59 54.3%
	Medtronic MDT	25 3.8%
	Stryker SYK	10 11.1%

Analyzing X Mentions, how is Glaukos performing compared to its industry peers?

Glaukos underperforms its industry peers when it comes to X Mentions, ranking in the 2nd percentile.

Why should an investor track X mentions?

Investors should track mentions of Glaukos on X because sudden increases in activity often reflect shifts in retail interest, sentiment, or breaking news. These signals can precede sharp price movements, offering valuable context for timing trades or identifying emerging opportunities.

Sentiment on X

The sentiment score for Glaukos on X is 82 (out of 100). This is considered bullish.

Top Mentions

$GKOS sharp reversal post fda approval yesterday on separate news related to a macs meeting next month...

Oct 21 - 0 retweets

Top Market Movers: Negative News Full Access: https://t.co/uSjYVzxIpW $GKOS [74.49$] [-6.27%] [October...

Oct 21 - 0 retweets

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.